Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 111Neoplasms 22Neoplasm Metastasis 17Brain Neoplasms 15Breast Neoplasms, Male 13Head and Neck Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Stomach Neoplasms 5Glioblastoma 5Colorectal Neoplasms 5Prostatic Neoplasms 4Ovarian Neoplasms 4Inflammatory Breast Neoplasms 4Carcinoma, Ovarian Epithelial 4Salivary Gland Neoplasms 3Lung Neoplasms 3Gliosarcoma 3Glioma 3Ependymoma 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Solid Tumors 2Recurrence 2Osteitis Deformans 2Oligodendroglioma 2Neuroma, Acoustic 2Neurofibromatosis 2 2Gallbladder Neoplasms 2Esophageal Neoplasms 2

Interventions

Temozolomide 6Cyclophosphamide 4antineoplaston AS 2-1 3antineoplaston A10 3Radiotherapy 3Filgrastim 3sargramostim 2aldesleukin 2Vincristine 2Thalidomide 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Irinotecan 2Donepezil 2Cisplatin 2Carmustine 2Bevacizumab 2veliparib 1trametinib 1temsirolimus 1surufatinib 1spartalizumab 1sonidegib 1ribociclib 1reolysin 1plerixafor 1ganitumab 1fosbretabulin 1entinostat 1dactolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neuroectodermal Tumors, Primitive × Lapatinib × Clear all
NCT00883688 2020-08-26

Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma

M.D. Anderson Cancer Center

Phase 2 Completed
24 enrolled 5 charts
CNS

Brain Neoplasms, Ependymoma, Neuroectodermal Tumors, Primitive, Glioma, Subependymal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡